DUSA Files Form S-3 Shelf Registration Statement (Marketwire)

yahoo.com     May 16, 2008            

WILMINGTON, MASSACHUSETTS--(MARKET WIRE)--May 16, 2008 -- DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced the filing of a... [read full story]                

Full Coverage

DUSA Files Form S-3 Shelf Registration Statement

newsblaze.com     May 16, 2008          

DUSA Pharmaceuticals, Inc. , a dermatology company that is developing and marketing Levulan photodynamic therapy and other products targeting patients with common skin conditions, today announced the filing of a shelf registration statement with the Secu                

comments

DUSA Pharmaceuticals, Inc.: DUSA Files Form S-3 Shelf Registration Statement

marketwire.com     May 16, 2008          

WILMINGTON, MASSACHUSETTS (MARKET WIRE) DUSA Pharmaceuticals, Inc.(R) (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan(R) photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced the filing of a shelf...                

comments

DUSA Files Form S-3 Shelf Registration Statement

marketwire.com     May 16, 2008          

WILMINGTON, MASSACHUSETTS--(Marketwire - May 16, 2008) - DUSA Pharmaceuticals, Inc.(R) (NASDAQ GM:DUSA), a dermatology company that is developing and marketing Levulan(R) photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced the filing of a...                

comments